Burkina Faso vs Eswatini: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Burkina Faso
98.0%
in 2014
Eswatini
98.0%
in 2014
Burkina Faso rank
22nd
Eswatini rank
22nd
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Burkina Faso
- Eswatini
How they compare
Burkina Faso currently reports 98.0% against 98.0% in Eswatini, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2006 it was Eswatini ahead.
Burkina Faso ranks 22nd and Eswatini ranks 22nd of 104 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Eswatini in 1.
Head to head by decade
| Decade | Burkina Faso | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.2% | 92.8% | 0.5% | Eswatini |
| 2010s | 97.4% | 96.2% | 1.2% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Burkina Faso or Eswatini?
- Burkina Faso, at 98.0% against 98.0% in Eswatini as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Burkina Faso and Eswatini?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Eswatini?
- 9 years are reported by both, from 2006 to 2014.
- How do Burkina Faso and Eswatini rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Burkina Faso ranks 22nd and Eswatini ranks 22nd of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.